Fundraising Fox
/People
Sign in

Mike Grey

Executive at Curzion Pharmaceuticals Inc · Executive Chairman at Plexium

Park City, Utah, United States

Find your path to Mike

89 people in our graph share verified history with Mike — schools, employers, funds. One of them is your warm intro.

Niall O'DonnellunlockedMike: together at Lumena Pharmaceuticals Inc. (2011–2013)
Mike: together at Auspex Pharmaceuticals
×3Mike: together at Amplyx Pharmaceuticals
Mike: together at Theolytics

About

Mike Grey is a biotechnology executive and board member who serves as Chair at Alethio Therapeutics. He holds chair or executive chair roles at Mirum Pharmaceuticals, Spruce Biosciences, Plexium, Sorriso Pharmaceuticals, and Theolytics, and sits on the boards of Mirum, Reneo, Spruce, Sorriso, Plexium, and Horizon Therapeutics.

Executive at Curzion Pharmaceuticals Inc

Intro paths

→

In turn, Mike can intro founders to Curzion Pharmaceuticals Inc's investors below.

Curzion Pharmaceuticals Inc's investors · 2

New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2019RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2019

Executive Chairman at Plexium

Intro paths

→

In turn, Mike can intro founders to Plexium's investors below.

Plexium's investors · 10

aMoonRa'anana · since 2025CRV (Charles River Ventures)Bay Area · $250K – $5M checks · since 2025DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2025Lux CapitalNew York · $100K – $100M checks · since 2021M VenturesLos Angeles · $10.8M checks · since 2025Neotribe VenturesMenlo Park · $250K – $2M checks · since 2025Pivotal Life SciencesSan Francisco · since 2025SoftBank Vision FundLondon · since 2025TCG CrossoverPalo Alto · since 2025The Column GroupSan Francisco · $30M checks · since 2025

Experience

  1. Alethio TherapeuticsChaircurrent2025 — presentAbingdon-On-Thames, England, United Kingdom
  2. TheolyticsExecutive Chaircurrent2023 — presentOxford, England, United Kingdom
  3. Sorriso PharmaceuticalsChairmancurrent2021 — present
  4. PlexiumExecutive Chairmancurrent2020 — present
  5. Mirum Pharmaceuticals, Inc.Chairmancurrent2018 — presentSan Francisco Bay Area
  6. Spruce BiosciencesExecutive Chairmancurrent2017 — present
  7. Pappas VenturesVenture Partnercurrent2010 — present
  8. Reneo PharmaceuticalsExecutive Chairman2014 — 2026
  9. Amplyx Pharmaceuticals, Inc.Executive Chairman2015 — 2021San Diego County, California, United States
  10. ZIARCO GROUP LIMITEDExecutive Chairman2014 — 2017Sandwich, England, United Kingdom
  11. Lumena Pharmaceuticals Inc.President & CEO2011 — 2014
  12. Auspex PharmaceuticalsCEO2009
  13. SGX PharmaceuticalsCEO2001 — 2008
  14. SGXCEO2001 — 2008
  15. Trega BiosciencesCEO1999 — 2001
  16. BioChem TherapeuticPresident1994 — 1998
  17. Biochem PharmaPresident, Biochem Therapeutics1994 — 1998
  18. GlaxoVP, Corporate Development1974 — 1993

Frequently asked questions

Who is Mike Grey?
Mike Grey is a biotechnology executive and board member who serves as Chair at Alethio Therapeutics. He holds chair or executive chair roles at Mirum Pharmaceuticals, Spruce Biosciences, Plexium, Sorriso Pharmaceuticals, and Theolytics, and sits on the boards of Mirum, Reneo, Spruce, Sorriso, Plexium, and Horizon Therapeutics.
Where does Mike Grey work?
Mike Grey is Executive at Curzion Pharmaceuticals Inc and Executive Chairman at Plexium.

Founder mafias

Theolytics mafia2

Also came through, then founded or led a company.

Henning SteinhagenBoard Director and Co-lead investorFounded Symeres

Shared employers

Also worked at Lumena Pharmaceuticals Inc.1

Niall O'DonnellManaging Director at RiverVest Venture Partners